Mebias Discovery announced it raised $631,000 in an initial filing from an offering of $2.05 Million
Mebias Discovery announced it raised $631,000 in an initial filing from an offering of $2.05 Million
09/23/22, 6:38 PM
Location
Money raised
$631,000
Industry
healthcare
Round Type
seed
Company Info
Location
3675 market street, suite 200
philadelphia, pennsylvania, united states
Additional Info
MEBIAS’ business model is comprised of partnering and advancing its own molecules into early clinical development. Six years since its founding, the company has validated its unique drug discovery, identified a novel preclinical mu-opioid candidate entering Phase 1 human clinical studies in 2022, and currently developing Sphingosine 1-phosphate receptor (S1PR1) agonists for the treatment of neuropathic pain.